Summary:
|
Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment page 2 :Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions instead of saline solutions in arterial lines page 6: Febuxostat: updated advice for the treatment of patients with a history of major cardiovascular disease
|
File Size:
|
327KB
|
Type:
|
Files / Images
|
Created:
|
25 May 2023
|
Last Modified:
|
28 June 2023
|